174 related articles for article (PubMed ID: 18614968)
21. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
Velasco G; Geelen MJ; Guzmán M
Arch Biochem Biophys; 1997 Jan; 337(2):169-75. PubMed ID: 9016810
[TBL] [Abstract][Full Text] [Related]
22. Malonyl-CoA decarboxylase is not a substrate of AMP-activated protein kinase in rat fast-twitch skeletal muscle or an islet cell line.
Habinowski SA; Hirshman M; Sakamoto K; Kemp BE; Gould SJ; Goodyear LJ; Witters LA
Arch Biochem Biophys; 2001 Dec; 396(1):71-9. PubMed ID: 11716464
[TBL] [Abstract][Full Text] [Related]
23. Volume overload hypertrophy of the newborn heart slows the maturation of enzymes involved in the regulation of fatty acid metabolism.
Kantor PF; Robertson MA; Coe JY; Lopaschuk GD
J Am Coll Cardiol; 1999 May; 33(6):1724-34. PubMed ID: 10334449
[TBL] [Abstract][Full Text] [Related]
24. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase.
Kudo N; Barr AJ; Barr RL; Desai S; Lopaschuk GD
J Biol Chem; 1995 Jul; 270(29):17513-20. PubMed ID: 7615556
[TBL] [Abstract][Full Text] [Related]
25. Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism.
Dyck JR; Berthiaume LG; Thomas PD; Kantor PF; Barr AJ; Barr R; Singh D; Hopkins TA; Voilley N; Prentki M; Lopaschuk GD
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):599-608. PubMed ID: 10947976
[TBL] [Abstract][Full Text] [Related]
26. Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo.
Chien D; Dean D; Saha AK; Flatt JP; Ruderman NB
Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E259-65. PubMed ID: 10913024
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and structure-activity relationship of small-molecule malonyl coenzyme A decarboxylase inhibitors.
Cheng JF; Chen M; Wallace D; Tith S; Haramura M; Liu B; Mak CC; Arrhenius T; Reily S; Brown S; Thorn V; Harmon C; Barr R; Dyck JR; Lopaschuk GD; Nadzan AM
J Med Chem; 2006 Mar; 49(5):1517-25. PubMed ID: 16509570
[TBL] [Abstract][Full Text] [Related]
28. AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment.
Steinberg GR; Rush JW; Dyck DJ
Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E648-54. PubMed ID: 12441311
[TBL] [Abstract][Full Text] [Related]
29. Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise.
Roepstorff C; Halberg N; Hillig T; Saha AK; Ruderman NB; Wojtaszewski JF; Richter EA; Kiens B
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E133-42. PubMed ID: 15383373
[TBL] [Abstract][Full Text] [Related]
30. Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart.
Sakamoto J; Barr RL; Kavanagh KM; Lopaschuk GD
Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1196-204. PubMed ID: 10749714
[TBL] [Abstract][Full Text] [Related]
31. Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1.
Singh KK; Shukla PC; Yanagawa B; Quan A; Lovren F; Pan Y; Wagg CS; Teoh H; Lopaschuk GD; Verma S
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):702-9. PubMed ID: 23317938
[TBL] [Abstract][Full Text] [Related]
32. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
[TBL] [Abstract][Full Text] [Related]
33. AMPK and ACC phosphorylation: effect of leptin, muscle fibre type and obesity.
Janovská A; Hatzinikolas G; Staikopoulos V; McInerney J; Mano M; Wittert GA
Mol Cell Endocrinol; 2008 Mar; 284(1-2):1-10. PubMed ID: 18255222
[TBL] [Abstract][Full Text] [Related]
34. Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats.
Atkinson LL; Kozak R; Kelly SE; Onay Besikci A; Russell JC; Lopaschuk GD
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E923-30. PubMed ID: 12464581
[TBL] [Abstract][Full Text] [Related]
35. Isoproterenol stimulates 5'-AMP-activated protein kinase and fatty acid oxidation in neonatal hearts.
Jaswal JS; Lund CR; Keung W; Beker DL; Rebeyka IM; Lopaschuk GD
Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1135-45. PubMed ID: 20656883
[TBL] [Abstract][Full Text] [Related]
36. AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during low-intensity muscle contraction.
Raney MA; Yee AJ; Todd MK; Turcotte LP
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E592-8. PubMed ID: 15547141
[TBL] [Abstract][Full Text] [Related]
37. Ca
Meng Y; Ding P; Wang H; Yang X; Wang Z; Nie D; Liu J; Huang Y; Su G; Hu J; Su Y; Du X; Dong N; Jia H; Zhang H; Zhang J; Li J
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jun; 1867(6):159120. PubMed ID: 35231606
[TBL] [Abstract][Full Text] [Related]
38. Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion.
Ussher JR; Lopaschuk GD
Basic Res Cardiol; 2009 Mar; 104(2):203-10. PubMed ID: 19242641
[TBL] [Abstract][Full Text] [Related]
39. Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity.
Thupari JN; Pinn ML; Kuhajda FP
Biochem Biophys Res Commun; 2001 Jul; 285(2):217-23. PubMed ID: 11444828
[TBL] [Abstract][Full Text] [Related]
40. Malonyl CoA control of fatty acid oxidation in the diabetic rat heart.
Lopaschuk GD
Adv Exp Med Biol; 2001; 498():155-65. PubMed ID: 11900364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
